Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Proportions of Cancer Cases in Primary Care, Hospital, and Cancer Registry Data Among Patients Treated for Overactive Bladder.

Margulis AV, Fortuny J, Kaye JA, Calingaert B, Reynolds M, Plana E, McQuay LJ, Atsma WJ, Franks B, de Vogel S, Perez-Gutthann S, Arana A.

Epidemiology. 2019 Mar;30(2):e8-e9. doi: 10.1097/EDE.0000000000000953. No abstract available.

PMID:
30489349
2.

Patterns of use of antimuscarinic drugs to treat overactive bladder in Denmark, Sweden, and the United Kingdom.

Margulis AV, Linder M, Arana A, Pottegård A, Berglind IA, Bui CL, Kristiansen NS, Bahmanyar S, McQuay LJ, Atsma WJ, Appenteng K, D'Silva M, Perez-Gutthann S, Hallas J.

PLoS One. 2018 Sep 27;13(9):e0204456. doi: 10.1371/journal.pone.0204456. eCollection 2018.

3.

Value of Free-text Comments for Validating Cancer Cases Using Primary-care Data in the United Kingdom.

Margulis AV, Fortuny J, Kaye JA, Calingaert B, Reynolds M, Plana E, McQuay LJ, Atsma WJ, Franks B, de Vogel S, Perez-Gutthann S, Arana A.

Epidemiology. 2018 Sep;29(5):e41-e42. doi: 10.1097/EDE.0000000000000856. No abstract available.

PMID:
29794511
4.

Responsible Epidemiologic Research Practice: a guideline developed by a working group of the Netherlands Epidemiological Society.

Swaen GMH, Langendam M, Weyler J, Burger H, Siesling S, Atsma WJ, Bouter L.

J Clin Epidemiol. 2018 Aug;100:111-119. doi: 10.1016/j.jclinepi.2018.02.010. Epub 2018 Feb 10.

5.

Incidence of Common Cancers in Users of Antimuscarinic Medications for Overactive Bladder: A Danish Nationwide Cohort Study.

Hallas J, Margulis AV, Pottegård A, Kristiansen NS, Atsma WJ, Appenteng K, de Vogel S, Kaye JA, Perez-Gutthann S, Arana A.

Basic Clin Pharmacol Toxicol. 2018 Jun;122(6):612-619. doi: 10.1111/bcpt.12965. Epub 2018 Feb 22.

6.

Validation of Cancer Cases Using Primary Care, Cancer Registry, and Hospitalization Data in the United Kingdom.

Margulis AV, Fortuny J, Kaye JA, Calingaert B, Reynolds M, Plana E, McQuay LJ, Atsma WJ, Franks B, de Vogel S, Perez-Gutthann S, Arana A.

Epidemiology. 2018 Mar;29(2):308-313. doi: 10.1097/EDE.0000000000000786.

7.

Comparison of cardiovascular events among treatments for overactive bladder: a Danish nationwide cohort study.

Margulis AV, Hallas J, Pottegård A, Kristiansen NS, Atsma WJ, Franks B, D'Silva M, Varas-Lorenzo C, Perez-Gutthann S, Arana A.

Eur J Clin Pharmacol. 2018 Feb;74(2):193-199. doi: 10.1007/s00228-017-2359-3. Epub 2017 Nov 13.

PMID:
29134254
8.

Voluntary timing of food intake increases weight gain and reduces basal plasma cortisol levels in common carp (Cyprinus carpio L.).

Klaren PH, van Dalen SC, Atsma W, Spanings FA, Hendriks J, Flik G.

Physiol Behav. 2013 Oct 2;122:120-8. doi: 10.1016/j.physbeh.2013.08.020. Epub 2013 Sep 14.

PMID:
24041723
9.

High levels of corticosterone, and gene expression of star, cyp17a2, hsd3b, cyp21, hsd11b2 during acute stress in common carp with interrenal hyperplasia.

Nematollahi MA, van Pelt-Heerschap H, Atsma W, Komen J.

Gen Comp Endocrinol. 2012 Apr 1;176(2):252-8. doi: 10.1016/j.ygcen.2012.01.023. Epub 2012 Feb 7.

PMID:
22333211
10.

Estimating post-marketing exposure to pharmaceutical products using ex-factory distribution data.

Telfair T, Mohan AK, Shahani S, Klincewicz S, Atsma WJ, Thomas A, Fife D.

Pharmacoepidemiol Drug Saf. 2006 Oct;15(10):749-53.

PMID:
16758501
11.

Organ-related distribution of phospholemman in the spiny dogfish Squalus acanthias.

Schuurmans Stekhoven FM, Grell E, Atsma W, Flik G, Wendelaar Bonga SE.

Biochem Biophys Res Commun. 2003 Apr 18;303(4):1008-11.

PMID:
12684034
12.

Effects of estrogens and hormone replacement therapy on breast cancer risk and on efficacy of breast cancer therapies.

Verheul HA, Coelingh-Bennink HJ, Kenemans P, Atsma WJ, Burger CW, Eden JA, Hammar M, Marsden J, Purdie DW.

Maturitas. 2000 Jul 31;36(1):1-17. Review.

PMID:
10989237
13.

Effects of sea water and stanniectomy on branchial Ca(2+) handling and drinking rate in eel (Anguilla anguilla L.).

van der Heijden AJ, Verbost PM, Bijvelds MJ, Atsma W, Wendelaar Bonga SE, Flik G.

J Exp Biol. 1999;202(Pt 18):2505-2511.

15.

Artificial intelligence analysis of paraspinal power spectra.

Oliver CW, Atsma WJ.

Clin Biomech (Bristol, Avon). 1996 Oct;11(7):422-424.

PMID:
11415655
16.

Scare over oral contraceptives. Risk is highest during first months of use.

Reijnen HB, Atsma WJ.

BMJ. 1995 Dec 16;311(7020):1639. No abstract available.

17.
18.

Is Livial diabetogenic?

Atsma WJ.

Maturitas. 1994 Oct;19(3):239-40. No abstract available.

PMID:
7799830
19.

Studies on stanniocalcin: characterization of bioactive and antigenic domains of the hormone.

Verbost PM, Butkus A, Atsma W, Willems P, Flik G, Bonga SE.

Mol Cell Endocrinol. 1993 May;93(1):11-6.

PMID:
7686517
20.

A role for di-acetyl alpha-melanocyte-stimulating hormone in the control of cortisol release in the teleost Oreochromis mossambicus.

Lamers AE, Flik G, Atsma W, Wendelaar Bonga SE.

J Endocrinol. 1992 Nov;135(2):285-92.

PMID:
1335471
22.

Site-specific epsilon-NH2 monoacylation of pancreatic phospholipase A2. 2. Transformation of soluble phospholipase A2 into a highly penetrating "membrane-bound" form.

Van der Wiele FC, Atsma W, Roelofsen B, van Linde M, Van Binsbergen J, Radvanyi F, Raykova D, Slotboom AJ, De Haas GH.

Biochemistry. 1988 Mar 8;27(5):1688-94.

PMID:
3130102
23.

Site-specific epsilon-NH2 monoacylation of pancreatic phospholipase A2. 1. Preparation and properties.

Van der Wiele FC, Atsma W, Dijkman R, Schreurs AM, Slotboom AJ, De Haas GH.

Biochemistry. 1988 Mar 8;27(5):1683-8.

PMID:
3130101

Supplemental Content

Support Center